Psilocybin’s therapeutic benefits have been recognized by the medical industry too. The Johns Hopkins Center for Psychedelic and Consciousness Research has invested in a psychedelic and psilocybin therapy and research center, thanks to $17 million in funding, so that researchers can learn more about psychedelics, how they can help treat illness, and develop new treatments for behavioral disorders.